QS: QuantumScape Stock Price, Analysis & Forecast: 1 Year and 5 Year Targets
QuantumScape: 1-Year and 5-Year Forecast Outlook and Rating
QuantumScape (QS) has an immediate Hold & Monitor consensus AI recommendation, based on 11 AI analysts.
The 1-year target is $2.98 for , with +6.81% expected return (+6.81% including net dividends) and a NEUTRAL rating.
The 5-year target is $3.39 for , with +21.51% expected return (+21.51% including net dividends) and a NEUTRAL rating.
Latest available market price: USD 2.79, as of 20 Nov 2026.
Dividend calculation details
Calculated net annual dividend yield: 0%. As of 2026-11-20.
Gross TTM: 0% · Two-year annualized gross: 0%.
Tax withholding assumption: 30% (US). One-off special payments are excluded.
Original published assumption: 0% per year.
Return estimates compound the net annual yield at a constant rate over the stated return horizon (the remaining time to the fixed target date for current returns): (1 + price return) × (1 + net annual yield)years − 1.
Targets retain their original publication dates. Returns use the dated market close and the time remaining to each fixed target date. Current ratings also require fresh quotes and analysis, with more than 90 days remaining. Past targets have no forward return. Eligibility checked .
QuantumScape Flagship Insight
The Battery Breakthrough Still Needs a Bankable Bridge to Shareholder Value

QuantumScape’s separator progress supports licensing and premium storage opportunities, but partner funding and manufacturing economics remain unresolved. There is high consensus on dilution exposure and erratic volatility. PowerCo negotiations, specialty-line financing and binding customer orders determine whether technical gains become sustainable cash flow per share.
How were the Investment Thesis and Forecasts created?
11 AI advisors, guided by 9 analytical frameworks, contribute to the deep analysis by iPulse AI Engine.
Michael Burry (Vulture)
Ray Dalio (Strategist)
J.P. Morgan (Titan)
Universal Investor (Polymath)
Sherlock Holmes (Whistleblower)
Elon Musk (Visionary)
Superintelligence (Anthropologist)
Warren Buffett (Value Purist)
Machiavelli (Insider)
Ran across these frontier AI models
Google Gemini 4 Hydrogen
OpenAI GPT-6.1 Sol
Anthropic Claude Opus 5.5
Latest published deep-analysis batch. Audit published forecasts in full transparency
QuantumScape: Investment Thesis Summary
Dotted terms link to the glossary; hover or focus for a preview. Browse technical terms
If you invest $10,000 in QuantumScape at the latest market close (20 Nov 2026): $12,151 by Nov 2031 versus $14,502 for S&P 500 benchmark.
Returns use the same dated market close, fixed targets and remaining dividend period as the forecast table.
QuantumScape is a financing bridge disguised as a battery option: separator progress can increase enterprise value while dilution reduces existing shareholders’ participation. The base case retains gradual specialty commercialization and later automotive licensing, but the planned owned production line prevents treating the business as purely asset-light. PowerCo’s payment suspension exposes customer bargaining power precisely when equipment commitments approach. Valuation remains sensitive to saleable yield, negotiated royalty capture and discount rates, not merely technical milestones. The strongest counterargument is that prepaid specialty orders or a bankable license could simultaneously finance learning and validate demand. Neither outcome is established by research agreements or laboratory cycling.
Key insights
- Customer-funded equipment has dual value: it lowers dilution and reveals willingness to pay, making financing terms an unusually informative signal of product economics.
- A small specialty line can validate processes and reference pricing without generating enough gross profit to fund the broader research organization or automotive ramp.
- Royalty prepayments improve liquidity immediately but can offset later collections, so contractual revenue visibility need not translate into equivalent incremental operating cash.
Continue reading QuantumScape analysis with Base subscription
See Base accessQuantumScape: 5 Year Consensus Forecast
20 quarterly price targets, returns and rationale, with advisor range and benchmark
Forward returns are updated using the latest market close price of USD 2.79, as of 20 Nov 2026.
Dividend calculation details
Calculated net annual dividend yield: 0%. As of 2026-11-20.
Gross TTM: 0% · Two-year annualized gross: 0%.
Tax withholding assumption: 30% (US). One-off special payments are excluded.
Original published assumption: 0% per year.
Return estimates compound the net annual yield at a constant rate over the stated return horizon (the remaining time to the fixed target date for current returns): (1 + price return) × (1 + net annual yield)years − 1.
The consensus target follows an expert-weighted price path synthesized from 11 AI advisor opinions. See Opinion weights and rationale for the exact allocation and reasoning.
Forecast methodology and reference values
Published targets are anchored on 13 Nov 2026 at USD 3.68. Original quarter-to-quarter target changes are retained. Forward returns use the remaining time to each fixed target date.
The pessimistic and optimistic advisor base cases are the lowest and highest published advisor base-case targets for each quarter. The advisor at either extreme can change between quarters. Benchmark values are in USD.
Scroll the table horizontally to read every column.
| Quarter | Consensus target (USD) | Forecast quarter-to-quarter price change | Forward price return | Forward return incl. net dividends | Forecast rationale | Pessimistic Advisor Base Case (USD) | Optimistic Advisor Base Case (USD) | S&P 500 benchmark (USD) |
|---|---|---|---|---|---|---|---|---|
| $3.33 | -9.62% | +19.35% | +19.35% | Annual capital planning shifts attention from separator demonstrations to the funding required for commercial capacity. Unresolved PowerCo payments and continuing cash consumption dominate, while the technical platform and treasury resources limit an immediate distress interpretation. | $3.03 | $3.50 | $736 | |
| $3.25 | -2.31% | +16.49% | +16.49% | Continued evaluations and possible clarification of a narrower PowerCo work plan provide some reassurance. However, customer receipts remain inadequate against development spending in the weighted scenario, leaving financing requirements more influential than incremental technical progress. | $2.72 | $3.73 | $724 | |
| $3.19 | -1.85% | +14.34% | +14.34% | Paid development activity and more consistent samples support intermittent relief, but anticipated specialty-line procurement keeps ownership dilution in focus. The balance favors caution because technical validation has not yet become sufficiently funded, binding production demand. | $2.88 | $3.55 | $722 | |
| $2.98 | -6.52% | +6.81% | +6.81% | Equipment commitments and another year of development spending sharpen the distinction between company survival and value per existing share. Assumed financing pressure outweighs customer-validation progress, although the reports disagree on whether issuance occurs this early. | $2.54 | $3.71 | $724 | |
| $2.88 | -3.53% | +3.23% | +3.23% | Equipment progress offers evidence against fundamental technology failure, but deposits, installation costs and expanded ownership claims weigh more heavily. The scenario emphasizes cash committed before receipts rather than treating the production-start window as automatic monetization. | $2.34 | $3.42 | $735 | |
| $2.94 | +2.32% | +5.38% | +5.38% | Visible equipment integration and customer qualification progress reduce commissioning uncertainty, supporting a recovery in commercial credibility. Installation spending remains a counterweight, and the more cautious views require saleable-cell economics before accepting a durable improvement. | $2.31 | $3.73 | $752 | |
| $3.05 | +3.71% | +9.32% | +9.32% | Commissioning milestones and possible initial specialty shipments bring customer acceptance closer to the investment case. This supports renewed confidence, while uncertain scrap rates and potential financing remind investors that nameplate capacity is not profitable output. | $2.43 | $4.07 | $754 | |
| $3.02 | -0.93% | +8.24% | +8.24% | Early deliveries improve the commercialization story, but low utilization, qualification support and financing needs limit their value. The weighted balance favors renewed scrutiny of cash contribution rather than extrapolating initial shipments into mature manufacturing margins. | $2.54 | $4.11 | $780 | |
| $3.02 | -0.19% | +8.24% | +8.24% | Repeat orders and improving output provide tangible support, yet working capital and renewed financing concerns absorb much of that progress. The scenario remains finely balanced between commercial validation and the ownership cost of sustaining production. | $2.35 | $4.02 | $802 | |
| $3.04 | +0.68% | +8.96% | +8.96% | Specialty reorders and further partner validation improve prospective utilization and revenue visibility. Their benefit is restrained by possible capital raising and technology-transfer friction, making this a tentative improvement rather than evidence that the financing bridge has closed. | $2.48 | $4.30 | $819 | |
| $3.14 | +3.29% | +12.54% | +12.54% | More reproducible production and advancing automotive licensing discussions strengthen confidence that the separator can be transferred beyond pilot equipment. Competitive pricing and uneven factory economics remain important constraints, preventing technical acceptance from guaranteeing attractive royalty capture. | $2.45 | $4.61 | $821 | |
| $3.17 | +0.98% | +13.62% | +13.62% | Limited licensing receipts and repeat specialty business make monetization less hypothetical, supporting a measured improvement. Slower automotive volume conversion and royalty-prepayment credits remain unresolved, so stronger headline receipts do not yet establish equivalent recurring cash generation. | $2.54 | $4.84 | $842 | |
| $3.14 | -0.94% | +12.54% | +12.54% | Further development and automotive support costs compete with increasingly concrete licensing prospects. Possible financing top-ups and continuing cash losses outweigh incremental commercial evidence in the weighted scenario, preserving the distinction between enterprise progress and shareholder participation. | $2.39 | $5.03 | $863 | |
| $3.24 | +3.14% | +16.13% | +16.13% | Yield stabilization and more consistent customer acceptance improve contribution per saleable cell. Emerging technology-transfer or royalty receipts add support, although competing battery prices and continuing development spending constrain how quickly those gains become corporate cash generation. | $2.57 | $4.89 | $871 | |
| $3.35 | +3.48% | +20.07% | +20.07% | A larger licensing component and improving accepted-cell output strengthen prospective operating leverage. Working-capital absorption and prepayment credits temper the cash benefit, while disagreement persists over whether customer scale can support attractive economics before another financing round. | $2.45 | $5.27 | $874 | |
| $3.31 | -1.23% | +18.64% | +18.64% | Customer procurement pressure and continuing cash absorption challenge the valuation awarded to earlier commercial progress. Expanding programs provide a counterweight, but the balance favors caution as investors distinguish recurring franchise economics from temporary improvements in shipments. | $2.53 | $5.54 | $896 | |
| $3.38 | +2.27% | +21.15% | +21.15% | More recurring licensing activity and steadier specialty demand improve revenue quality and visibility. Continuing platform expenditure prevents a clean profitability conclusion, but the business increasingly earns valuation support from commercial evidence rather than laboratory optionality alone. | $2.54 | $5.76 | $912 | |
| $3.45 | +1.82% | +23.66% | +23.66% | Repeat purchasing and better utilization reduce uncertainty around the operating cost base, supporting commercial value. Negotiated royalty rates and customer bargaining power remain limiting factors, so improving receipts do not justify assuming software-like pricing economics. | $2.53 | $6.04 | $924 | |
| $3.47 | +0.75% | +24.37% | +24.37% | Steadier licensed production and specialty renewals support a modest improvement in franchise visibility. Persistent losses, equity compensation and stricter valuation assumptions offset part of that benefit, with reports still divided on the proximity of self-funding operations. | $2.50 | $5.93 | $939 | |
| $3.39 | -2.39% | +21.51% | +21.51% | Terminal scrutiny centers on the gap between useful technology and sustainable free cash flow. Commercial traction supports continuing platform value, but accumulated dilution and incomplete profitability constrain the multiple investors can justify for remaining execution-sensitive growth. | $2.53 | $6.17 | $965 |
Show remaining 18 quartersCollapse to first 2 quarters
All 20 quarters are displayed in the table above.
QuantumScape Stock Analysis & Scenarios Deep Dive
QuantumScape: Alpha Gap & Repricing Catalysts
Market Narrative
What does the market currently expect? The externally cited evidence suggests a skeptical commercialization trade, not an insolvency consensus. Dated analyst cuts and cautious estimates emphasize automotive delays and dilution, while media coverage and speculative trading retain enthusiasm for AI storage and laboratory milestones. Pricing beyond treasury assets implies residual platform expectations, but that is an inference; the inputs provide opposing crowd narratives, not a verified positioning survey.
Alpha Gap
What is the biggest difference between market expectations and our AI forecasts? The crowd appears to overestimate value modestly, although the inputs do not establish a measured market-wide pricing error. The strongest supported gap is between technical relevance and bankable economics: broader separator compatibility does not itself improve royalty terms or finance owned capacity. That weakens the case for treating a depressed share price as inexpensive optionality. Substantial liquidity limits immediate distress, while binding customer-funded orders could overturn the cautious interpretation by validating demand and reducing dilution together.
Repricing Catalyst
What could make the market recognize and close that gap? The 2027 capital plan and a disclosed PowerCo agreement are the clearest tests because enforceable cash commitments cannot be substituted with technical demonstrations. Through the first half, funding requirements exceeding restored partner support would strengthen the dilution concern. Binding specialty orders during 2027–2029, followed by production licenses through 2030, could reverse that interpretation. Repricing requires credible funding and customer acceptance; laboratory progress alone may not close the gap.
QuantumScape: Sentiment and Timing
What do sentiment, volatility, and the market-recognition cycle suggest about the thesis timing?
- Greed and Fear Sentiment
- Fear
- Volatility Regime
- High Erratic
- Convergence Cycle Position
- Reversal
Fear and erratic volatility are consistent across the reports; disagreement concerns whether selling is nearing capitulation or still reversing earlier technical enthusiasm. That distinction makes funding disclosures more useful for timing than the size of the prior drawdown.
Macro Regime Fit
Does the current market environment support the thesis? The setup is a net headwind under the supplied restrictive-rate scenario. Expensive capital discounts distant royalties and makes both shareholder financing and customer factory commitments harder. AI infrastructure investment and domestic sourcing preferences offer selective demand support, but QuantumScape’s decisive exposure is financing an unproven production ramp, not aggregate battery-market growth.
Advisor Disagreement
What do our AI Advisors disagree about most? The central economic disagreement is whether specialty demand and royalties scale before financing materially dilutes existing holders. Constructive paths assume customer funding, improving utilization and easier capital conditions; cautious paths retain viable technology but slower monetization and weaker bargaining power. Runway differences partly reflect definitions: historical liquidity decline includes partner inflows, whereas free cash flow and expansion budgets measure different burdens. Some analyses also conflate equipment participation with committed project financing. Disclosed saleable yields, binding purchase terms and a fully funded capital plan would resolve more than another laboratory milestone.
Thesis Change
What changed in the thesis since the previous forecast? The investment case has shifted from presumed licensing-led underpricing to financing-sensitive optionality, while the underlying separator technology remains commercially unproven. -- Previously, partner-funded scale and an anticipated royalty prepayment supported a pronounced valuation gap. Current filings describe suspended PowerCo milestone payments and reduced commitments, weakening that funding assumption. -- The planned company-owned specialty line adds investment exposure before recurring sales. Osprey and Honda broaden technical relevance, but funded orders and saleable yields now determine whether progress benefits existing shareholders.
QuantumScape: Critical Influencing Factors
Near-certain positive forcesTop Drivers & Tailwinds
Near-certain forces that support the investment thesis. These forces are treated as part of the base case (at least 75% probability of occurrence, as generation guidance). Impact columns are specific to this asset class.
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| Separator relevance outlasts automotive delays | Innovation And Product | +35% | +25% | The ceramic separator retains technical option value even if automotive launches slip. Company-reported Osprey compatibility with solid cathodes broadens potential licensing applications beyond the original cell architecture. Continued validation should preserve prospective earnings opportunities across the horizon, but laboratory cycling does not establish commercial-format reliability, manufacturing cost or customer willingness to pay. |
| Automation turns samples into learning | Operational Efficiency | +25% | +18% | Higher repeatable pilot output improves the feedback loop between defects, customer testing and process correction. Cobra and Eagle Line progress provide a foundation for cheaper experimentation and more credible technology transfer. These learning benefits should persist, although reported tool uptime is not saleable-cell yield and cannot establish fully loaded production economics. |
| Partners limit the factory bill | Capital Allocation | +25% | +25% | Partner-led automotive production avoids requiring QuantumScape to finance every incremental gigafactory, preserving prospective royalty margins and reducing ultimate capital requirements. Current spending restraint also protects development resources. The benefit remains material across the horizon, but equipment suppliers do not automatically finance the company-owned specialty line, and partner dependence limits economic capture. |
| Premium niches widen paid evaluation | Sector And Industry | +22% | +18% | Initial nonautomotive billings and Honda engagement broaden the evaluation funnel beyond Volkswagen. Data-center, aerospace and defense applications may value compact, reliable power more than commodity battery buyers, supporting development receipts and prospective premium sales. Continued engagement is the base-case benefit; binding volume awards, attractive margins and meaningful diversification of cash flow remain unproven. |
Near-certain negative forcesTop Frictions & Headwinds
Near-certain forces that could slow, cap, or damage the thesis. These forces are treated as part of the base case (at least 75% probability of occurrence, as generation guidance). Impact columns are specific to this asset class.
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| More shares divide the prize | Capital Allocation | -35% | -0.0% | Financing must arrive before recurring commercial cash generation, making equity issuance and employee compensation a persistent ownership cost. The liquidity buffer reduces urgency but does not fund an unlimited industrialization program. A larger share denominator can absorb enterprise-value gains throughout the horizon; dilution itself reduces ownership per share, not aggregate company earnings. |
| PowerCo resets the funding bridge | Competitive Positioning | -30% | -15% | Suspended milestone payments and reduced transition commitments expose the difference between industrial endorsement and unconditional funding. Even if collaboration survives, revised scope and customer leverage can postpone receipts and constrain royalty capture. This bargaining asymmetry should remain relevant until alternative production customers become credible, lowering expected monetization without requiring outright partner termination. |
| Factory learning consumes early margins | Operational Efficiency | -30% | -20% | Ordinary industrialization costs can delay profitability without any fundamental chemistry failure. Equipment integration, scrap, qualification support and low utilization must improve together before specialty shipments generate meaningful cash contribution. These demands should persist through much of the horizon, making initial revenue less valuable than mature licensing comparisons suggest and extending the financing bridge. |
| Incumbents keep moving the benchmark | Competitive Positioning | -20% | -15% | QuantumScape must compete against improving batteries available at customer launch, not historical lithium-ion performance. Established manufacturing scale, LFP cost reductions and alternative solid-state programs preserve buyer choice. Persistent competition should constrain premium applications and negotiated royalties, even if separator differentiation survives; technical merit therefore need not produce monopoly-like margins or valuation multiples. |
QuantumScape: What Could Break or Accelerate the Thesis
Event Risk Score: Very High 95/100Asset-level relative pressure from clustered consensus frictions and tail risks. This is not the probability or risk score of an individual force.Plausible downside scenariosTail Risks
Tail yet plausible downside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| PowerCo abandons the commercial pathway | 35% | -60% | A formal termination or substantial abandonment during 2027–2030 would be materially worse than the payment suspension already reflected in the base case. Losing the principal automotive industrialization reference would impair royalty expectations and weaken negotiations with replacement customers and financiers. Continuing collaboration and Volkswagen’s existing involvement keep this a tail event rather than an assumed outcome. |
| Qualification failure forces recapitalization | 30% | -65% | Representative production lots or customer testing during 2027–2030 could expose persistent reliability defects or uneconomic yields requiring redesign. Delayed receipts and repeated qualification would consume liquidity precisely when financing confidence weakens, potentially forcing a deeply discounted recapitalization. Successful samples reduce the probability, but undisclosed commercial yields prevent pilot progress from eliminating this severe ownership risk. |
Plausible upside scenariosTail Opportunities
Tail yet plausible upside scenarios selected for their highest potential impact.
Scroll to view all columns
| Tail scenario | Chance of Occurring | Stock Price Impact | Why plausible / what changes |
|---|---|---|---|
| Specialty customer underwrites production | 30% | +140% | A named hyperscaler, infrastructure integrator or defense customer could sign a binding, prepaid production agreement during 2027–2029. Equipment funding and minimum purchases would validate pricing while reducing dilution, giving the same contract both commercial and financing value. Probability remains limited because field qualification, procurement approval and reliable saleable output have not been established. |
| Automotive license becomes bankable | 25% | +140% | A definitive, funded automotive production license during 2027–2030 could convert evaluation into enforceable economics, through restored PowerCo commitments or an independent Honda/Osprey award. Prepayments and a credible industrial timetable would reduce financing uncertainty and support recurring royalty expectations. The event remains a minority outcome because representative-cell qualification, manufacturing transfer and acceptable commercial terms are unresolved. |
Company Financial AnalysisQuantumScape: Earnings and Financials Analysis by AI
Financial figures available as of Nov 16, 2026. Only filings and source records available by this analysis date are included. View latest QuantumScape financials here.
Earnings and financials
QuantumScape’s Q3 2026 Form 10-Q describes a development business, not an established sales franchise. The quarterly net loss narrowed to $84.5 million, but accounting benefits and lower noncash expenses contributed to that improvement. Conflicting revenue entries in external feeds should not be treated as recurring battery sales; customer billings and partner contributions require separate accounting treatment. Operating cash consumption of $55.1 million, reported with the quarterly results, is the more useful measure of the immediate burden. Honda and nonautomotive engagement broaden potential demand, but invoices do not establish repeat orders or gross profit. The financial improvement is breathing room, not yet a self-sustaining revenue engine.
Revenue, earnings, and cash flow
The table compares up to five fiscal years of revenue, net income, and free cash flow available to this analysis.
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | USD 0 | USD -435.1M | USD -278.8M |
| 2024 | USD 0 | USD -477.9M | USD -336.7M |
| 2023 | USD 0 | USD -445.1M | USD -324.5M |
| 2022 | USD 0 | USD -411.9M | USD -376.9M |
| 2021 | USD 0 | USD -46M | USD -255.1M |
Valuation context: historical P/E
The table compares up to five fiscal years of point-in-time valuation evidence available to this analysis.
| Fiscal year | P/E | Earnings basis | Currency basis | Ticker / reporting |
|---|---|---|---|---|
| 2025 | -- | TTM | Loss-making | USD / USD |
| 2024 | -- | TTM | Loss-making | USD / USD |
| 2023 | -- | TTM | Loss-making | USD / USD |
| 2022 | -- | Annual | Loss-making | USD / USD |
| 2021 | -- | Annual | Loss-making | USD / USD |
P/E uses historical market capitalization and earnings known at each period. Cross-currency observations are normalized to USD using point-in-time FX rates.
Profitability and margins
There is no reliable commercial margin to extrapolate while principal operations remain pre-revenue. The Q3 2026 Form 10-Q records an $8.1 million reversal of milestone compensation after achievement became improbable. That lowers reported expenses but also signals execution uncertainty; it is not evidence that batteries became cheaper to manufacture. Spending restraint provides genuine runway support, yet future profitability depends on the mix of royalties and owned specialty production. Royalties could carry attractive incremental margins, while direct production introduces scrap, low utilization and warranty costs. The reports disagree on how quickly these burdens fade. Earnings-impact percentages therefore describe modeled changes in losses, not conventional growth from an established profit base.
The table compares up to five fiscal years of operating income and reported profitability margins.
| Fiscal year | Operating income | Operating margin | Net margin |
|---|---|---|---|
| 2025 | USD -472.6M | -- | -- |
| 2024 | USD -511.9M | -- | -- |
| 2023 | USD -457.5M | -- | -- |
| 2022 | USD -420.6M | -- | -- |
| 2021 | USD -215.3M | -- | -- |
Balance sheet and leverage
The September 2026 Form 10-Q and quarterly materials report $819.8 million in cash and marketable securities. That substantial treasury portfolio and minimal conventional borrowing reduce immediate refinancing pressure. However, lease obligations, facility commitments and future equipment spending mean liquidity is not simply surplus cash available to shareholders. Against the supplied trailing free-cash-flow deficit of $259 million, resources provide multiyear static coverage, not assured funding through commercial maturity. PowerCo’s suspended payments weaken the bridge just as production investment approaches. The main vulnerability is therefore ownership dilution before cash generation, rather than an imminent debt crisis. Subtracting every liability from liquidity also should not be confused with standard net cash.
The table compares up to five fiscal years of debt, liquidity, net cash or debt, and current-ratio evidence.
| Fiscal year | Total debt | Cash + short-term investments | Reported net cash / (debt) | Debt less (cash + short-term investments), calculated | Current ratio |
|---|---|---|---|---|---|
| 2025 | USD 71M | USD 970.8M | USD 159.5M net cash | USD -899.8M | 15.95x |
| 2024 | USD 93.5M | USD 910.8M | USD 47.3M net cash | USD -817.2M | 14.21x |
| 2023 | USD 100.6M | USD 1.1B | USD 41.9M net cash | USD -970.2M | 18.98x |
| 2022 | USD 105.4M | USD 1.1B | USD 130M net cash | USD -956.3M | 22.91x |
| 2021 | USD 77.4M | USD 1.4B | USD 243.3M net cash | USD -1.4B | 47.81x |
Reported net debt retains the source definition, which can deduct cash alone. Cash plus short-term investments is broader liquidity; the separately calculated column subtracts that full amount from total debt for the same fiscal period and currency. Reported net debt below zero is displayed as net cash. Current ratio is current assets divided by current liabilities.
Capex and investment intensity
Management’s Q3 2026 shareholder letter guided annual capital spending to $27–37 million, showing restraint after pilot-line investment. Automotive licensing can keep enormous factory bills with partners, but low current capital spending does not mean low overall investment: research and development still consumes substantial cash. The separately announced 100-MWh specialty line introduces QuantumScape’s own equipment, qualification and eventual working-capital requirements. Muehlbauer’s involvement provides an industrialization route, not proof that the project is fully financed. Some reports emphasize outsourcing; the stronger interpretation distinguishes equipment suppliers from committed funders. Shareholders are financing a commercial proving ground whose payback remains dependent on customer commitments and reliable production.
The table compares up to five fiscal years of capital expenditure and research-and-development investment.
| Fiscal year | Capital expenditure | R&D spend |
|---|---|---|
| 2025 | USD 36.3M | USD 375.6M |
| 2024 | USD 62.1M | USD 311.8M |
| 2023 | USD 84.5M | USD 284.5M |
| 2022 | USD 158.8M | USD 269.2M |
| 2021 | USD 127.2M | USD 140.3M |
Behind the synthesisQuantumScape: How Each Individual AI Forecaster Opinion Shapes the Global Consensus
This publication’s recorded synthesis allocated voting influence across 11 advisor opinions. The weights and rationales below are retained from that synthesis.
The strongest common pattern rests on complementary evidence: SEC disclosures show conditional partner funding and continuing cash consumption, company announcements establish a broader technical and customer funnel, and supplied industry material supports persistent incumbent competition. These are not eleven independent confirmations. Highest weights go to analyses that reconcile billings with revenue, distinguish owned specialty capacity from licensee factories, and bridge enterprise value to diluted ownership. The strongest credible opposing case is customer-funded commercialization: binding orders could validate pricing while reducing financing needs. It receives meaningful weight, but assumed federal awards, automatic monetary easing and seamless royalty ramps are discounted. Several bearish treatments also overstate immediate cash exhaustion or subtract all liabilities when describing net cash. Unresolved saleable yields, contractual economics and financing terms prevent a high-confidence valuation verdict. Factor earnings sensitivities are nonadditive and use differing loss denominators.
Individual targets retain their original dates. Returns and ratings use the same latest available market close and dividend assumptions as the Consensus.
All 11 opinions
Consensus weight Allocation: 17.0/100. Weight Allocation Rationale: Strong filing-level reconciliation separates billings, revenue and accounting benefits, while explicitly connecting owned production investment to dilution. Its valuation bridge is transparent and causally consistent. Shared company sources limit independence, and assumed financing timing and terminal revenue remain uncertain rather than documented commitments.
The 1-year target is $2.79 for , with -0.05% expected return and a PARTIAL SELL rating. The 5-year target is $2.75 for , with -1.51% expected return and a PARTIAL SELL rating.
Consensus weight Allocation: 16.0/100. Weight Allocation Rationale: Primary-source reconciliation, explicit financing uncertainty and a useful capacity-to-revenue cross-check make this a strong perspective. It distinguishes technical survival from shareholder economics without requiring technology failure. The assumed selling price, terminal share count and financing cadence remain scenario inputs, and several underlying sources overlap other reports.
The 1-year target is $2.53 for , with -9.20% expected return and a SELL ALL rating. The 5-year target is $2.58 for , with -7.64% expected return and a PARTIAL SELL rating.
Consensus weight Allocation: 14.0/100. Weight Allocation Rationale: Careful treatment of leases, conditional payments and royalty-prepayment credits adds distinctive accounting and cash-flow insight. The distinction between industrial access and pricing power is well supported. Shared primary sources constrain independence, while assumed licensing advances and continued technical collaboration leave meaningful uncertainty in the more constructive path.
The 1-year target is $3.72 for , with +33.19% expected return and a STRONG BUY rating. The 5-year target is $4.26 for , with +52.86% expected return and a BUY rating.
Consensus weight Allocation: 12.0/100. Weight Allocation Rationale: Strong primary-source use supports the distinction between technical achievement, funded production and value per existing share. The treatment of prepayment credits and owned-production risks is especially useful. Weight is tempered by substantial assumed financing and dilution, stylized quarterly issuance timing, and a different earnings-impact denominator.
The 1-year target is $2.78 for , with -0.39% expected return and a PARTIAL SELL rating. The 5-year target is $2.78 for , with -0.35% expected return and a PARTIAL SELL rating.
Consensus weight Allocation: 10.0/100. Weight Allocation Rationale: Detailed contract amendments and a clear enterprise-value-versus-share-count bridge strengthen the analysis. Its sponsor-bargaining insight survives scrutiny. Weight is moderated because historical net liquidity decline incorporates partner inflows, making the longer runway estimate conditional, while equipment partnerships do not establish that partners finance the specialty line.
The 1-year target is $3.27 for , with +17.03% expected return and a STRONG BUY rating. The 5-year target is $2.94 for , with +5.33% expected return and a PARTIAL SELL rating.
Consensus weight Allocation: 8.0/100. Weight Allocation Rationale: The commercialization-gap argument correctly links suspended funding, renewed manufacturing exposure and dilution. Contract and compensation observations are corroborated by supplied filing excerpts. Domain-only sourcing limits traceability, while claims about predominantly accounting-driven improvement and an approaching cash cliff are stronger than the reconciled evidence warrants.
The 1-year target is $2.69 for , with -3.47% expected return and a SELL ALL rating. The 5-year target is $3.16 for , with +13.24% expected return and a PARTIAL SELL rating.
Consensus weight Allocation: 6.0/100. Weight Allocation Rationale: The separation of near-term solvency from continuing ownership dilution is valuable and consistent with supplied filings. However, subtracting total liabilities from liquidity is not conventional net cash, and some prospective licensed capacity is described too firmly. Overlapping secondary coverage also limits independent evidential contribution.
The 1-year target is $2.66 for , with -4.53% expected return and a SELL ALL rating. The 5-year target is $3.10 for , with +11.22% expected return and a PARTIAL SELL rating.
Consensus weight Allocation: 6.0/100. Weight Allocation Rationale: The analysis usefully reconciles anomalous revenue feeds and recognizes that owned specialty production weakens a purely licensing-based valuation. Its recovery case deserves representation. However, later margin improvement and cash-flow stabilization are less substantiated than the near-term funding risks, with substantial reliance on overlapping secondary commentary.
The 1-year target is $3.15 for , with +12.83% expected return and a STRONG BUY rating. The 5-year target is $4.50 for , with +61.14% expected return and a BUY rating.
Consensus weight Allocation: 5.0/100. Weight Allocation Rationale: The interaction between financing conditions, customer investment and long-duration valuation is economically coherent. Its recovery case preserves credible specialty-market optionality. Nevertheless, eventual easing and successful royalty conversion are assumed rather than established, and repeated macro figures and company announcements do not supply independent confirmation.
The 1-year target is $3.17 for , with +13.76% expected return and a STRONG BUY rating. The 5-year target is $4.92 for , with +76.25% expected return and a BUY rating.
Consensus weight Allocation: 4.0/100. Weight Allocation Rationale: The distinction between automotive funding pressure and premium domestic applications is useful. However, prospective federal awards, procurement advantages and recurring specialty traction carry more explanatory weight than the supplied receipts justify. Overlapping company and secondary sources provide limited independent support for the optimistic commercialization path.
The 1-year target is $3.31 for , with +18.73% expected return and a STRONG BUY rating. The 5-year target is $6.17 for , with +121.03% expected return and a STRONG BUY rating.
Consensus weight Allocation: 2.0/100. Weight Allocation Rationale: The negative cash-generation and dilution mechanisms remain relevant, so exclusion is unwarranted. The unusually low weight reflects absent source receipts, unreconciled revenue treatment and insufficient incorporation of current contract amendments and owned specialty capacity. Repeated valuation and macro assertions add little independent evidence beyond better-supported reports.
The 1-year target is $3.25 for , with +16.47% expected return and a STRONG BUY rating. The 5-year target is $2.53 for , with -9.38% expected return and a PARTIAL SELL rating.
References & Context
Research Provenance
Analysis generated by iPulse AI Engine v9 using recorded market data, operating under the editorial standards and supervision of Russlan Ramdowar, Editor-in-Chief.
External references below are sources recorded by the researcher agents for this QuantumScape forecast batch.
Primary analysis inputs
- iPulse AI Multi-Agent Forecasts — independent analyst personas, model outputs, and consensus synthesis.
- iPulse AI Global Events Context — macroeconomic, geopolitical, regulatory, and industry-event context.
- Structured market history — prices, distributions, volatility, identifiers, and listing metadata.
- Company earnings and financial statements — revenue, profitability, balance-sheet, cash-flow, and investment trends.
- Researcher web evidence — public sources consulted to challenge and contextualize the forecast thesis.
Sources retained from AI Researcher searches
Asset-specific · Researcher web40 available sources from this batch (87 recorded). The first 15 are shown below; expand to read the rest.
Some model providers retained only the consulted domain, not an exact article URL. Those domains are shown as evidence without inventing a link.
- 10-Q sec.gov
- sec.gov sec.gov
- www.sec.gov sec.gov
- 460235_QUANTUMSCAPE_COMBO_PROOF_ARS_.pdf sec.gov
- QuantumScape Corp - Form 10-Q - FY2025 sec.gov
- QuantumScape Corp - Form 10-Q - FY2026 sec.gov
- QuantumScape Corp - Form 10-Q - FY2026 sec.gov
- QuantumScape Corp - Form 8-K - FY2026 sec.gov
- QuantumScape Corp - Form 8-K - FY2026 sec.gov
- QuantumScape Corp - Form 8-K - FY2026 sec.gov
- QuantumScape Corp - Form 8-K - FY2026 sec.gov
- quantumscape.com quantumscape.com
- geminiq.com geminiq.com
- reddit.com reddit.com
- stocktitan.net stocktitan.net
Show 25 more sources
- seekingalpha.com seekingalpha.com
- tradingview.com tradingview.com
- biggo.com biggo.com
- electrek.co electrek.co
- finsee.ai finsee.ai
- globenewswire.com globenewswire.com
- batterytechonline.com batterytechonline.com
- fool.com fool.com
- QuantumScape Announces Plans for 100 MWh Solid-State Battery Production Line for AI Data Centers, Aerospace and Defense | Wed, 10/21/2026 - 16:15 ir.quantumscape.com
- kalkine.com kalkine.com
- youtube.com youtube.com
- benzinga.com benzinga.com
- gurufocus.com gurufocus.com
- insidedeeptech.com insidedeeptech.com
- kreatebots.com kreatebots.com
- ventureatlas.org ventureatlas.org
- 247wallst.com 247wallst.com
- investing.com investing.com
- 0001193125-26-427862 | 8-K | iXBRL Viewer | Quantumscape Corp ir.quantumscape.com
- Q3 2026 Shareholder Letter ir.quantumscape.com
- QuantumScape Announces Agreement with Honda on Solid-State Battery Technology | Thu, 06/18/2026 - 09:00 ir.quantumscape.com
- QuantumScape Expands Commercial Roadmap with Osprey, the Open All-Solid-State Platform for Battery Development | Wed, 11/11/2026 - 09:00 ir.quantumscape.com
- Osprey: The Open Solid-State Platform - QuantumScape quantumscape.com
- stockanalysis.com stockanalysis.com
- basisreport.com basisreport.com
47 additional sources are recorded in this batch; their citation details are not available in this publication.
Context retained with this Consensus
The same public-safe market, global-event, and fundamental context supplied to the AI Advisor panel.
Global context snapshot
2026 Year-to-Date Global Market and World-Events Context Through November 14
Download Archived SnapshotCoverage 2026-01-01 to 2026-11-14 · Knowledge cutoff 2026-11-14
January 1-November 14, 2026: persistent inflation, partial oil supply recovery, US midterms and trade, AI financing, and uneven growth.
Archived context covering 2026-01-01 to 2026-11-14. Its recorded scope includes monetary policy and rates; geopolitics energy and shipping; trade and industrial policy. Selected highlights reflect the analysis cutoff, not current world conditions.
Show moreShow less
- File size
- 96K bytes
- Words
- 14.2K words
- Characters
- 96K characters
- Est. tokens (characters ÷ 4)
- 24K tokens
Fed held at 3.75%-4.00%; Democrats won the next Congress, Nvidia changed leadership and Anthropic filed preliminary IPO terms. Markets through November 13.
| Selected highlights from this archived snapshot | Date | Status |
|---|---|---|
| Renewed monetary tightening amid persistent inflation | 2026-01-30 | ACTIVE POLICY REGIME |
| Iran/Hormuz conflict and wider energy-security disruption | 2026-02-28 | ONGOING |
| US tariff reset, trade truce and incoming divided government | 2026-02-20 | ACTIVE POLICY REGIME |
Representative Sources of the Context File
And more sources from the retained context package.
Fundamental Context Passed as Input to the Models
Time range: Annual fiscal periods: 2018-12-31–2025-12-31, 8 periods; Quarterly fiscal periods: 2023-12-31–2026-09-30, 12 periods.
Currencies cited: USD (quote USD; primary reporting USD; converted/valuation USD).
Show moreShow less
Income statement
9 fieldsdepreciationAndAmortization · ebit · ebitda · grossProfit · +5 more fields
Balance sheet
11 fieldscash · commonStockSharesOutstanding · netDebt · netReceivables · +7 more fields
Cash flow
5 fieldscapitalExpenditures · dividendsPaid · freeCashFlow · salePurchaseOfStock · +1 more field
End of the paywalled preview
The excerpt from Deep Dive: detailed analysis to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.
Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.
Additional with full access
Individual AI Advisor reports
- Investment theses
- Bull and bear scenarios and alpha signals
- Drivers, headwinds, risks and opportunities
- Quarterly forecast rationale
- Advisor research references and configuration
Additional datasets and interactive tools
- Interactive forecast comparisons
- Available detailed financial statements
- Market history and corporate-action adjustments
- Eligible historical publication workspaces
Explore complete public research examples
These public assets show the complete AI Consensus research. Their findings concern those assets, not this report.
QuantumScape: forecast questions
What is QuantumScape (QS)'s 1-year price forecast?
QuantumScape's 1-year target is $2.98 for Nov 2027. The current AI rating is NEUTRAL. The expected return from the recorded close is +6.81%, or +6.81% modeled return including net dividends. Latest available market price: USD 2.79, as of 20 Nov 2026. The target date is fixed at publication.
What is QuantumScape (QS)'s 5-year price forecast?
QuantumScape's 5-year target is $3.39 for Nov 2031. The current AI rating is NEUTRAL. The expected return from the recorded close is +21.51%, or +21.51% modeled return including net dividends. Latest available market price: USD 2.79, as of 20 Nov 2026. The target date is fixed at publication.
How can I compare the AI opinions and audit past QuantumScape forecasts?
11 AI analysts contribute to this publication. AI Opinions shows individual advisor forecasts and reasoning. Forecast History lists the available batches with their original publication dates.
How does an AI-generated forecast for QuantumScape differ from Wall Street analyst consensus?
Wall Street consensus aggregates estimates from human analysts. For listed companies, these typically include brokerage price targets, earnings forecasts and ratings. iPulse AI's forecast for QuantumScape is a separate AI consensus generated through its own research workflow. Different inputs, forecast dates, assumptions and weighting can therefore produce different targets.
We believe the era of investment research conducted only by human analysts is drawing to a close. Frontier models increasingly match or exceed expert work on selected professional benchmarks, including evaluations covering financial analysis. Research on multi-model synthesis also shows that combining model responses can improve on a single model's output in the tasks studied.
iPulse AI generates transparent investment research and market forecasts using a swarm of AI configurations, analytical frameworks and frontier models. The workflow applies multiple verification, challenge and synthesis layers, with selective editorial review under Russlan Ramdowar, Editor-in-Chief. Published assumptions, disagreements and past forecasts remain available so readers can inspect the reasoning and audit outcomes.
For a research cycle covering 426 assets with 14 perspectives per asset, our internal workload model estimates approximately 114,000 hours of traditional analyst work. It assumes 16 hours per individual research report, 28 hours per consensus for synthesis and validation, plus shared data preparation. Parallel AI execution allows a deep-analysis cycle across hundreds of assets to complete in up to one day. The human-hours figure is an illustrative workload estimate, rather than measured time savings. Our research methodology explains the automated workflow.
If iPulse AI produces thousands of investment reports - work estimated to require over 100,000 traditional analyst hours - isn't that just "AI slop" at scale?
No. iPulse AI produces AI-generated research at scale, but the purpose is depth of analysis, comparison, and accountability. The number of reports is a consequence of the research process; it is not the goal.
iPulse AI does not produce thin copies of existing websites, articles, or investment reports. We use frontier models as an Analytical Intelligence layer. Our Financial Experts select, validate, curate, and supply the input data, including proprietary inputs, so the models work from a prepared evidence base.
In Researcher mode, models can also search the web to check current information, test assumptions, and investigate evidence that may be missing from the supplied data. This can include lobbying expenditure, management developments, regulatory decisions, or other facts relevant to a particular investment thesis. Thinker mode focuses on deep reasoning over the supplied data and context.
Our process goes much further than asking ChatGPT to evaluate a stock. Our team designs structured investment frameworks inspired by the approaches of influential investors, economists, political thinkers, and technological visionaries. These are AI analytical frameworks, not reports written or endorsed by the people who inspired them.
Each asset is analyzed separately through multiple frameworks and configurations, using specialized inputs and task instructions. Different perspectives examine different questions: valuation, business quality, technological disruption, macroeconomic conditions, political influence, financial risks, and more.
Cloud infrastructure allows these workflows to run at scale. That scale also comes with quality assurance at scale: up to 30% of report-generation attempts fail our QA checks. We rerun failed attempts until a clean report passes those checks. Users are presented only with reports that have passed QA.
This explains the volume. The value comes from what we do with the analysis.
A second layer synthesizes the individual reports into an asset-level consensus. This is where we recommend starting when researching a particular asset: it brings together the central thesis, supporting evidence, risks, and disagreements while preserving access to the underlying opinions.
We then compare assets through our proprietary iPulse AI Consensus Score, whose methodology is publicly explained. This helps users move from understanding one asset to comparing opportunities across the analyzed universe.
A further research and editorial layer examines leading candidates, checks current evidence, and develops focused Editorial Top Picks across broad-market and dedicated asset categories. Human editors review the evidence and approve each published edition. For example, explore our Best Long-Term Investments.
But the process does not end when a report is published. We preserve past forecasts so users with the relevant subscription can inspect what the system actually said and compare it with subsequent market outcomes. As more forecasts reach their target dates, the historical record becomes more useful for evaluating which approaches worked, which failed, and under what conditions.
We publish research on our website, arXiv, and Zenodo, alongside explanatory writing on Medium. We use the evidence to refine our data, frameworks, validation, and workflows, and document important findings in Lessons Learned.
The standard we ask users to judge us by is the reasoning, evidence, and historical record behind the research.
How does the iPulse AI Engine work?
The engine runs AI advisor configurations against a shared set of research inputs. The engine history explains the research workflow and what changed between versions.








